Optex Systems Outpaces Axon with 139.5% Surge vs 8.2% Gain
Optex Systems’ shares jumped 139.5% over the last year versus Axon’s 8.2% gain, driven by robust defense contracts and a $7.9 million Q1 2026 order intake. Optex trades at 2.06x EV/sales compared to Axon’s 16.44x, highlighting Axon’s premium valuation.
1. Performance Gap
Optex Systems has delivered a 139.5% share increase over the past 12 months compared to Axon’s 8.2% gain and the broader industry’s 46.2% growth, propelled by new defense contracts and a $7.9 million Q1 order intake.
2. Valuation Comparison
In valuation terms, Optex trades at a 2.06x trailing EV/sales multiple, significantly below Axon’s 16.44x ratio and the industry average of 14.71x, underscoring a stark premium on Axon’s shares.
3. Implications for Axon
Axon investors may reevaluate growth expectations as Optex’s robust backlog, long-term defense relationships and cost pressures shape competitive positioning and could intensify scrutiny on Axon’s relative operational performance.